Oxford BioMedica PLC (OXB) — Capital Reinvestment Ratio
Oxford BioMedica PLC (OXB) has a Capital Reinvestment Ratio of 0.64x as of June 2025, meaning it reinvests 1% of its operating cash flow (GBX2.35 Million) in capital expenditures (GBX1.51 Million). Check OXB goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oxford BioMedica PLC Capital Reinvestment Ratio (2007–2021)
This chart tracks Oxford BioMedica PLC's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see Oxford BioMedica PLC cash conversion from operations.
Annual Capital Reinvestment Ratio for Oxford BioMedica PLC (2007–2021)
Year-by-year Capital Reinvestment Ratio for Oxford BioMedica PLC from 2007 to 2021. See OXB cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.37x | GBX25.45 Million | GBX9.46 Million | ▼ -91.3% |
| 2020 | 4.29x | GBX3.12 Million | GBX13.36 Million | ▲ +443.6% |
| 2018 | 0.79x | GBX12.87 Million | GBX10.15 Million | ▲ +19.3% |
| 2017 | 0.66x | GBX2.98 Million | GBX1.97 Million | ▲ +431.1% |
| 2009 | 0.12x | GBX2.31 Million | GBX288.00K | ▲ +39.8% |
| 2007 | 0.09x | GBX4.73 Million | GBX421.00K | — |